| Financial Year |
March 31 2023 |
| Monetary Funds |
858,123,186.54 |
| Held-for-trading Financial Assets |
50,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
163,908,628.40 |
| Advances to Suppliers |
1,618,089.80 |
| Other Receivables |
7,805,090.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
117,829,619.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,308,473.73 |
| Total Current Assets |
1,221,219,081.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
27,691,038.89 |
| Fixed Assetes |
512,390,366.84 |
| Under-construction Projects |
4,112,701.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
36,070,650.95 |
| R&D expenses |
-- |
| Goodwill |
15,295,923.64 |
| Long-Term Deferred and Prepaid Expenses |
12,816,892.41 |
| Deferred Income Tax Assets |
6,833,034.31 |
| Other Non-Current Assets |
1,904,181.80 |
| Sub-Total of Non-Current Assets |
617,361,546.97 |
| Total Assets |
1,838,580,628.86 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
182,126,108.22 |
| Accounts Payable |
112,929,134.43 |
| Accounts Received In Advance |
615,849.84 |
| Employee Compensation Payable |
19,483,206.98 |
| Taxes Payable |
9,118,606.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,942,187.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
329,222,617.15 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,197,397.98 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
32,865,426.20 |
| Total Liabilities |
362,088,043.35 |
| Paid-In Capital(Or Share Stock) |
524,485,465.00 |
| Capital Surplus |
262,048,917.26 |
| Surplus Reserve |
51,436,942.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
620,841,644.58 |
| Minority Stockholder's Interest |
17,679,616.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,458,812,968.90 |
| Owner's Equity（Stockholder's Equity） |
1,476,492,585.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,838,580,628.86 |
